Astria Therapeutics (ATXS) Gains from Investment Securities: 2013-2024
Historic Gains from Investment Securities for Astria Therapeutics (ATXS) over the last 12 years, with Dec 2024 value amounting to $5.8 million.
- Astria Therapeutics' Gains from Investment Securities was N/A to -$317,000 in Q4 2019 from the same period last year, while for Dec 2019 it was -$1.6 million, marking a year-over-year change of. This contributed to the annual value of $5.8 million for FY2024, which is 12606.52% up from last year.
- As of FY2024, Astria Therapeutics' Gains from Investment Securities stood at $5.8 million, which was up 12,606.52% from -$46,000 recorded in FY2023.
- Astria Therapeutics' 5-year Gains from Investment Securities high stood at $5.8 million for FY2024, and its period low was -$58,000 during FY2020.
- Over the past 3 years, Astria Therapeutics' median Gains from Investment Securities value was $1.3 million (recorded in 2022), while the average stood at $2.3 million.
- Per our database at Business Quant, Astria Therapeutics' Gains from Investment Securities plummeted by 103.63% in 2023 and then spiked by 12,606.52% in 2024.
- Over the past 5 years, Astria Therapeutics' Gains from Investment Securities (Yearly) stood at -$58,000 in 2020, then soared by 63.79% to -$21,000 in 2021, then surged by 6,138.10% to $1.3 million in 2022, then tumbled by 103.63% to -$46,000 in 2023, then surged by 12,606.52% to $5.8 million in 2024.